AEVEX Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated April 16, 2026, details the consummation of AEVEX Corp.'s Initial Public Offering (IPO). The Company, incorporated in Delaware, lists its Class A common stock (Symbol: AVEX) on the New York Stock Exchange. The report covers events occurring between April 16, 2026, and April 20, 2026, including the entry into material definitive agreements and the closing of the IPO.
Key Financial Metrics and Capital Structure
The filing focuses on capital raising activities rather than historical operating performance. Key financial terms of the IPO include:
- Offering Price: $20.00 per share.
- Firm Shares Sold: 16,000,000 shares of Class A Common Stock.
- Option Shares: An additional 2,400,000 shares were sold upon the full exercise of the underwriters' 30-day option on April 17, 2026.
- Total Shares Issued in IPO: 18,400,000 shares.
- Unregistered Issuance: 63,297,524 shares of Class B Common Stock were issued to ATS Investment Holdings, LLC in connection with the IPO.
- Underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc., and Jefferies LLC.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics. These figures are referenced as being contained in the Prospectus filed on April 20, 2026.
Material Changes and Corporate Actions
The primary material change is the transition from a private to a public company. Significant corporate actions include:
- Entry into Material Definitive Agreements: Execution of the Underwriting Agreement, Registration Rights Agreement, Director Designation Agreement, Tax Receivable Agreement, and Exchange Agreement.
- Board Composition: Appointment of five new directors on April 16, 2026: Bradley Feldmann, Matthew Klein, Brandon Levitan, Matthew Norton, and Benjamin Spacapan.
- Governance Updates: Adoption of an Amended and Restated Certificate of Incorporation and Bylaws effective April 17, 2026.
- Compensation Plans: Adoption of the AEVEX Corp. 2026 Omnibus Incentive Plan and execution of indemnification agreements with directors and executive officers.
Guidance, Risks, and Contingencies
The filing does not contain forward-looking guidance, revenue outlook, or specific risk factors within the text provided. It references the Prospectus for detailed descriptions of risks, contingencies, and the Tax Receivable Agreement obligations. The Company has agreed to indemnify underwriters against certain liabilities under the Securities Act.
Investor Verification Checklist
- Prospectus Review: Verify the full text of the Prospectus (filed April 20, 2026) for detailed financial statements, risk factors, and use of proceeds.
- Capital Structure: Confirm the voting rights and conversion terms of the 63,297,524 Class B shares issued to ATS Investment Holdings, LLC.
- Tax Receivable Agreement: Review the Tax Receivable Agreement (Exhibit 10.3) to understand potential future cash outflows related to tax benefits.
- Board Independence: Assess the independence and qualifications of the newly appointed directors.
- Underwriting Terms: Confirm the final net proceeds to the Company after underwriting discounts and commissions.